Showing results (451-460 of 525) with videos related to
Sort By:
Pageof 53
Innovations (Philadelphia, Pa.)|March 23, 2012
Minimally invasive versus open mitral valve surgery: a consensus statement of the international society of minimally invasive coronary surgery (ISMICS) 2010Volkmar Falk, Davy C H Cheng, Janet Martin, et al.Pharmacology, Biochemistry, and Behavior|February 22, 2023
The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolismDavid B Finlay, Warwick Mackie, Hunter D J Webb, et al.AJR. American Journal of Roentgenology|February 1, 1976
Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized studyT C Lo, A L Wiley, F J Ansfield, et al.Clinical Biochemistry|April 11, 2013
Predicting respiratory distress syndrome using gestational age and lamellar body countQiuhong Zhao, Zhen Zhao, Van Leung-Pineda, et al.Analytical and Quantitative Cytology and Histology|May 26, 2005
Potential use of loss of heterozygosity in pleural effusions of breast cancer metastases using the microsatellite marker of the 16q22.1 region of the CDH1 geneNara de Matos Granja, Sara Alexandra Vinhas Ricardo, Adhemar Longatto Filho, et al.DNA Repair|February 13, 2009
In vitro complementation of Tdp1 deficiency indicates a stabilized enzyme-DNA adduct from tyrosyl but not glycolate lesions as a consequence of the SCAN1 mutationAmy J Hawkins, Mark A Subler, Konstantin Akopiants, et al.Bone Marrow Transplantation|July 22, 1999
Immunohistochemical detection of breast cancer cells in paired peripheral blood progenitor cell specimens collected after cytokine or cytokine and myelosuppressive chemotherapyM B Kleinman, E L Wiley, M Guo, et al.Health Physics|February 25, 2014
Role of dicentric analysis in an overarching biodosimetry strategy for use following a nuclear detonation in an urban environmentDaniel J Blumenthal, Stephen L Sugarman, Doran M Christensen, et al.Pharmacology Research & Perspectives|January 18, 2022
Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018David B Finlay, Thuy Nguyen, Thomas F Gamage, et al.Journal of Cancer Research and Clinical Oncology|June 15, 2007
IGF-II promoter methylation and ovarian cancer prognosisA C Beeghly, D Katsaros, A L Wiley, et al.Pageof 53